Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine
Author(s) -
Amedeo Capetti,
Carlo Alberto Stangalini,
Fabio Borgonovo,
Davide Mileto,
Letizia Oreni,
Gianfranco Dedivitiis,
A. Lupo,
Maria Vittoria Cossu,
Lara Bilardo,
Andrea Giacomelli,
Massimo Galli,
Giuliano Rizzardini
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab214
Subject(s) - covid-19 , medicine , virology , pandemic , boosting (machine learning) , coronavirus , antibody , infectious disease (medical specialty) , immunology , disease , computer science , artificial intelligence , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom